Omar M El Kawkgi, MD

1. Colbeth HL, Genere N, Hall CB, Jaber N, Brito JP, El Kawkgi OM, Goldfarb DG, Webber MP, Schwartz TM, Prezant DJ, Zeig-Owens R. Evaluation of Medical Surveillance and Incidence of Post-September 11, 2001, Thyroid Cancer in World Trade Center-Exposed Firefighters and Emergency Medical Service Workers. JAMA Intern Med. 2020 Jun 1;180(6):888-895. doi: 10.1001/jamainternmed.2020.0950. PMID: 32310290; PMCID: PMC7171583.

2. Li D, El Kawkgi OM, Morris JC 3rd. A Patient with Hyperthyroidism and An Anterior Mediastinal Mass. J Endocr Soc. 2020 Aug 21;4(10):bvaa124. doi: 10.1210/jendso/bvaa124. PMID: 32999948; PMCID: PMC7514796.

3. El Kawkgi OM, Ross DS, Stan MN. Comparison of long-term antithyroid drugs versus radioactive iodine or surgery for Graves' disease: A review of the literature. Clin Endocrinol (Oxf). 2021 Jul;95(1):3-12. doi: 10.1111/cen.14374. Epub 2020 Dec 6. PMID: 33283314 

4. El Kawkgi OM, Li D, Kotwal A, Wermers RA. Hypoparathyroidism: An Uncommon Complication Associated With Immune Checkpoint Inhibitor Therapy. Mayo Clin Proc Innov Qual Outcomes. 2020 Nov 3;4(6):821-825. doi: 10.1016/j.mayocpiqo.2020.07.006. PMID: 33367219; PMCID: PMC7749243.

5. Lincango-Naranjo E, Solis-Pazmino P, El Kawkgi O, Salazar-Vega J, Garcia C, Ledesma T, Rojas T, Alvarado-Mafla B, Young G, Dy B, Ponce OJ, Brito JP. Triggers of thyroid cancer diagnosis: a systematic review and meta-analysis. Endocrine. 2021 Jun;72(3):644-659. doi: 10.1007/s12020-020-02588-8. Epub 2021 Jan 29. PMID: 33512656. 

6. Brito JP, Ross JS, El Kawkgi OM, Maraka S, Deng Y, Shah ND, Lipska KJ. Levothyroxine Use in the United States, 2008-2018. JAMA Intern Med. 2021 Oct 1;181(10):1402-1405. doi: 10.1001/jamainternmed.2021.2686. PMID: 34152370; PMCID: PMC8218227. 

7. Genere N, El Kawkgi OM, Giblon RE, Vaccarella S, Morris JC, Hay ID, Brito JP. Incidence of Clinically Relevant Thyroid Cancers Remains Stable for Almost a Century: A Population-Based Study. Mayo Clin Proc. 2021 Nov;96(11):2823-2830. doi: 10.1016/j.mayocp.2021.04.028. PMID: 34736609; PMCID: PMC9645772. 

8. Kohlenberg J, Gu J, Parvinian A, Webb J, Kawkgi OE, Larson NB, Ryder M, Fatemi M, Alizad A. Added value of mass characteristic frequency to 2-D shear wave elastography for differentiation of benign and malignant thyroid nodules. Ultrasound Med Biol. 2022 Aug;48(8):1663-1671. doi: 10.1016/j.ultrasmedbio.2022.04.218. Epub 2022 Jun 4. PMID: 35672198; PMCID: PMC9246930. 

9. El Kawkgi OM, Stan MN. Radiofrequency Ablation for Papillary Thyroid Microcarcinoma Is Safe and Effective in Long-Term Follow-up. Clinical Thyroidology. 2021 Mar; 33(3):121-123.

10. El Kawkgi Omar, Brito Juan. Minority Populations with Thyroid Cancers Are Less Likely to Receive Specialist Care Clinical Thyroidology. 2022; 34(1):29-31.

11. Toro-Tobon David, El Kawkgi Omar. Risk of Second Primary Malignancy Associated with Cumulative Doses of Radioactive Iodine in Patients with Differentiated Thyroid Cance Clinical Thyroidology. 2023; 35(4):154-156.

12. El Kawkgi Omar. Deciphering Molecular Signatures Behind Different Radioactive Iodine Uptake Patterns in Differentiated Thyroid Cancer with Distant Metastases. Clinical Thyroidology. 2024;36(6):215-7.

13. El Kawkgi Omar. Increased Incidence or Detection Bias? Global Cohort Study Finds No Link between GLP1-RAs and Thyroid Cancer Risk. Clinical Thyroidology. 2025;36(1):33-36

14. El Kawkgi O, Toro-Tobon D, Toloza FJK, Vallejo S, Jacome CS, Ayala IN, Vallejo BA, Wenczenovicz C, Tzeng O, Spencer HJ, Thostenson JD, Li D, Kohlenberg J, Lincango E, Mohan S, Castellanos-Diaz J, Maraka S, Ospina NS, Brito JP. A Predictive Model for Graves' Disease Recurrence After Antithyroid Drug Therapy: A Retrospective Multicenter Cohort Study. Endocr Pract. 2025 Apr;31(4):455-464. doi: 10.1016/j.eprac.2024.12.011. Epub 2024 Dec 16. PMID: 39694327; PMCID: PMC12005976.